-
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
27 Mar 2024 15:33 GMT
… medicines at $35 a month for certain U.S. patients.
British drugmaker … ;s one holdout: Teva Pharmaceuticals, another major inhaler manufacturer … that the broader pharmaceutical industry has faced … HFA, Combivent Respimat and Spiriva products, among others.
…
-
Medicaid Change Sparks Warning for Children
26 Mar 2024 21:23 GMT
… as well as Symbicort and Spiriva HandiHaler and Atrovent HFA units … medications.
A man holds an albuterol sulfate inhaler, commonly used in the treatment … difficult to say whether other drug manufacturers will discontinue other inhalers …
-
Experts say Medicaid rebate change is behind inhaler price cuts
26 Mar 2024 13:10 GMT
… ATI Advisory’s Prescription Drug Reimbursement Practice. ‘It … Will Feldman, a pulmonary doctor with Brigham and Women’ … by the Medicaid rebate cap policy change than Spiriva HandiHaler,” … suit Teva brought against Amneal Pharmaceuticals, Inc., for attempting …
-
Drug Wars Continue Despite Registry Patent Listing Crackdown
25 Mar 2024 05:41 GMT
… federal registry of approved drugs than Teva Pharmaceutical Industries Ltd., the … FDA’s Orange Book goes on to help the generic-drug … 12 patents for asthma treatment. Seven of the patents … Boehringer’s top selling Spiriva HandiHaler. Alvogen in October …
-
2023 First Generic Drug Approvals
08 Mar 2024 22:36 GMT
… Package
B. Braun Medical, Inc.
Calcium Gluconate … 47;capsule
Lupin Inc
Spiriva HandiHaler (Tiotropium Bromide … once-daily, maintenance treatment of bronchospasm associated … 0.064%
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited
Enstilar ( …
-
Drugmaker caps its inhalers at $35 a month
08 Mar 2024 02:45 GMT
… struggle to pay for their medications. This new program supports patients … ’s primary asthma product is Spiriva® Respimat®, a long-acting bronchodilator …
-
Boehringer Ingelheim accused of misusing US patents to delay asthma-drug rivals
07 Mar 2024 07:38 GMT
… and our adherence to FDA guidelines," Boehringer said … of patents covering drugs that the FDA has deemed safe … #39;s lawsuit that pharmaceutical companies like Boehringer patent aspects … the drug and gouge patients.
The fund said that Spiriva Respimat …
-
Theravance’s Yupelri falls short in Phase IV COPD trial
05 Feb 2024 15:40 GMT
… biotech Theravance Biopharma’s chronic obstructive pulmonary disease (COPD) drug … Spiriva (tiotropium).
Findings from a separate Phase III clinical trial … FDA – it was secured in November 2018 following two clinical trials … of Clinical Trials Arena.
Access …
-
Indian drugmaker Lupin beats quarterly profit estimates on strong demand
08 Feb 2024 00:54 GMT
(Reuters) – Indian generic drugmaker Lupin reported a bigger-than- … follow those of larger generic drugmakers, including Dr. Reddy’s, Cipla … version of Boehringer Ingelheim’s Spiriva Handihaler, an inhaler used for …
-
Boehringer Ingelheim Korea initiates voluntary recall for COPD and asthma treatment
31 Jan 2024 02:02 GMT
… recall of select batches for Spiriva Respimat (ingredient: tiotropium bromide hydrate … medication is approved for use as a bronchodilator in the maintenance treatment … and an inhaler, with the drug indicator allowing users to ascertain …